The U.S. Food and Drug Administration has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Exdensur ...

Allied Market Research published a report, titled, 'Respiratory Inhaler Devices Market by Product (Metered Dose Inhalers, Dry ...

The toxic haze that blanketed large parts of India in November didn't just cloud the skies—it pushed sales of asthma and COPD medicines to their highest levels in three years.

Globally, more than 1 billion people currently live with obesity. The World Health Organization on Monday released new guidance on GLP-1 medications for adults with obesity, recommending their ...

Bronchiectasis hospitalizations have higher mortality and costs than COPD and asthma, with a median stay of 5 days and costs of $50,393. During the COVID-19 pandemic, bronchiectasis hospitalizations ...

Americans may pay less for prescription medications with the launch of TrumpRx.gov. The Trump administration presents the platform as a way to reduce drug costs using a Most-Favored-Nation (MFN) ...